Indivior (INVVY) Stock Forecast, Price & News

Indivior (OTCMKTS:INVVY) Frequently Asked Questions

Is Indivior a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Indivior stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INVVY, but not buy additional shares or sell existing shares.
View analyst ratings for Indivior or view top-rated stocks.

Are investors shorting Indivior?

Indivior saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 15,800 shares, an increase of 38.6% from the April 15th total of 11,400 shares. Based on an average daily trading volume, of 4,100 shares, the days-to-cover ratio is presently 3.9 days.
View Indivior's Short Interest.

Who are Indivior's key executives?

Indivior's management team includes the following people:

• Mr. Mark Crossley, CEO & Exec. Director
• Mr. Ryan Preblick, CFO & Exec. Director
• Dr. Christian Heidbreder, Chief Scientific Officer
• Mr. Jason Thompson, VP of Investor Relations
• Ms. Cynthia Cetani, Chief Integrity & Compliance Officer
• Mr. Jeffrey W. Burris, Chief Legal Officer (Age 50)
• Mr. Jon Fogle, Chief HR Officer
• Mr. Richard Simkin, Chief Commercial & Strategy Officer
• Mr. Hillel West, Chief Manufacturing & Supply Officer
• Ms. Kathryn Hudson, Company Sec.

Who are some of Indivior's key competitors?

Some companies that are related to Indivior include Biohaven Pharmaceutical (BHVN), Jazz Pharmaceuticals (JAZZ), Organon & Co. (OGN), Teva Pharmaceutical Industries (TEVA), Grifols (GRFS), United Therapeutics (UTHR), Dr. Reddy's Laboratories (RDY), Maravai LifeSciences (MRVI), Legend Biotech (LEGN), Sarepta Therapeutics (SRPT), Ionis Pharmaceuticals (IONS), Intra-Cellular Therapies (ITCI), Perrigo (PRGO), Ascendis Pharma A/S (ASND) and Hypera (HYPMY).
View all of INVVY's competitors.

What is Indivior's stock symbol?

Indivior trades on the OTCMKTS under the ticker symbol "INVVY."

How do I buy shares of Indivior?

Shares of INVVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Indivior's stock price today?

One share of INVVY stock can currently be purchased for approximately $19.02.

How much money does Indivior make?

Indivior has a market capitalization of $2.68 billion and generates $791 million in revenue each year. The company earns $205 million in net income (profit) each year or $1.10 on an earnings per share basis.

How many employees does Indivior have?

Indivior employs 800 workers across the globe.

What is Indivior's official website?

The official website for Indivior is www.indivior.com.

How can I contact Indivior?

Indivior's mailing address is 10710 Midlothian Turnpike, North Chesterfield VA, 23235. The company can be reached via phone at 804-379-1090, via email at [email protected], or via fax at 804-379-1215.